Brainstorm Cell Therapeutics
(OTC) BCLI
Brainstorm Cell Therapeutics Financials at a Glance
Market Cap
$10.19M
Revenue (TTM)
$0.00
Net Income (TTM)
$10.31M
EPS (TTM)
$-1.20
P/E Ratio
-0.77
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.92
Volume
26,319
Open
$0.91
Price
$0.92
Volume
26,319
Open
$0.91
Previous Close
$0.92
Daily Range
$0.88 - $0.92
52-Week Range
$0.46 - $0.97
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.92
Volume
26,319
Open
$0.91
Previous Close
$0.92
Daily Range
$0.88 - $0.92
52-Week Range
$0.46 - $0.97
BCLI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Brainstorm Cell Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
20
CEO
Chaim Lebovits
Website
www.brainstorm-cell.comHeadquarters
New York City, NY 10019, US
BCLI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
97%
Return on Assets
-14%
Earnings Yield
-1.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$10.19M
Shares Outstanding
11.03M
Volume
26.32K
Short Interest
0.00%
Avg. Volume
20.15K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$9.95M
EBITDA
$9.75M
Operating Cash Flow
$6.97M
Capital Expenditure
$0.00
Free Cash Flow
$6.97M
Cash & ST Invst.
$29.00K
Total Debt
$208.00K
Brainstorm Cell Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$48.00K
+9.4%
Gross Margin
0.00%
N/A
Market Cap
$10.19M
N/A
Market Cap/Employee
$377.23K
N/A
Employees
27
N/A
Net Income
$2.43M
+18.1%
EBITDA
$2.20M
+30.0%
Quarterly Fundamentals
Net Cash
$179.00K
+66.4%
Accounts Receivable
$86.00K
+36.5%
Inventory
$0.00
N/A
Long Term Debt
$208.00K
+21.6%
Short Term Debt
$1.18M
+114.0%
Return on Assets
-14.42%
N/A
Return on Invested Capital
96.71%
N/A
Free Cash Flow
$740.00K
+29.4%
Operating Cash Flow
$740.00K
+29.4%